Company / SG&A Expense
Tilray Brands, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$165.2M
FY2025
5-year range
$162.8M / $167.4M
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#86 of 213
Health Care
What the data says
At $165M, Tilray Brands, Inc.'s sg&a expense ranks #128 of 213 in the Health Care sector.
Based on SEC 10-K filings.
$165M in FY2025 with a 5-year CAGR of +12.0%.
Remained stable around $165M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
#128 of 213 in Health CareTop 60% of 213This company $165.2M Sector average $722.3M
▼
-77.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.0%, indicating consistent growth.
- In FY2025, sg&a expense decreased 1.3% year-over-year.
- Ranks #86 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $165.2M | -1.3% |
| FY2024 | $167.3M | -0.0% |
| FY2023 | $167.4M | +1.3% |
| FY2022 | $165.2M | +1.4% |
| FY2021 | $162.8M | +73.6% |
| FY2020 | $93.8M | +23.7% |
| FY2019 | $75.8M | +56.1% |
| FY2018 | $48.6M | +547.8% |
| FY2017 | $7.5M | +53.4% |
| FY2016 | $4.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026